Novartis Investigative Site

Samara, Samara Oblast 443095

0 studies enrolling now · 3 studies all time

What they study most

Relapsing Forms of Multiple Sclerosis, Tuberous Sclerosis Complex, Tuberous Sclerosis Complex-associated Refractory Seizures

Studies at this site

• Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment — Running, not enrolling
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures — Completed